Treatment with Adenosine Diphosphate Receptor Inhibitors—Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) study design: Expanding the paradigm of longitudinal observational research

Background Platelet inhibition is critical in reducing both short- and long-term atherothrombotic risks after acute myocardial infarction (MI), especially among patients managed with percutaneous coronary intervention (PCI). Currently available antiplatelet medications, including adenosine diphospha...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2011-11, Vol.162 (5), p.844-851
Hauptverfasser:	Chin, Chee Tang, MBChB, MRCP, Wang, Tracy Y., MD, MHS, MSc, Anstrom, Kevin J., PhD, Zhu, Baojin, PhD, Maa, Jen-Fue, PhD, Messenger, John C., MD, Ryan, Kelley A., BA, Davidson-Ray, Linda, Zettler, Marjorie, PhD, MPH, Effron, Mark B., MD, Mark, Daniel B., MD, Peterson, Eric D., MD, MPH
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Acute coronary syndromes Adenosine Biological and medical sciences Cardiology. Vascular system Cardiovascular Clinical medicine Coronary heart disease Drug therapy Heart Heart attacks Hospitalization Humans Longitudinal Studies Medical sciences Myocarditis. Cardiomyopathies Patient Selection Platelet Aggregation Inhibitors - administration & dosage Purinergic P2Y Receptor Antagonists - administration & dosage Randomized Controlled Trials as Topic Registries Research Design Stroke Thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!